Immune Therapeutics Inc. (IMUN) - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Immune Therapeutics Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-02-10
Purchase
2023-02-22
7:00 pm
Immune Therapeutics Inc.IMUNFarmer Glen A
Chief Financial Officer
409,000$0.045$18,405409,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2022-12-15
4:47 pm
N/A
N/A
Immune Therapeutics Inc.IMUNH. Louis Salomonsky Jr. Revocable Trust
10% Owner
0$012,168,880
(Direct)
View

Ownership
2022-12-15
4:46 pm
N/A
N/A
Immune Therapeutics Inc.IMUNSalomonsky Henry Louis
Director
10% Owner
0$012,168,900
(Direct)
View

Ownership
2022-12-15
4:44 pm
N/A
N/A
Immune Therapeutics Inc.IMUNWilson Kelly O'Brien
COO and ICEO and IP
10% Owner
0$019,307,145
(Direct)
View